Go to deals
Aerospace, Defense & Security | Construction & Engineering Services | Healthcare

Hydrix Limited (ASX:HYD) has raised capital via a placement

Hydrix Limited has completed a capital raise with institutional and sophisticated investors. The capital will be used to bolster the company’s growth strategy and to extinguish outstanding secured debt.

Hydrix is a product innovation company providing product development services for clients in large addressable global markets, including medical and industrial, and connected cardiovascular technologies and services throughout the Asia Pacific region. With over 200 successfully designed products and solutions, Hydrix is recognized as one of the leading product development companies in Australia. It has three core business segments: services, medical and ventures. The company is underpinned by world-class product development expertise within Hydris Services and is now leveraging these skill sets to create and capture the value that it creates for its customers via Hydrix Medical and Hydrix Ventures.

Oaklins’ team in Australia acted as co-manager in this transaction.

Talk to the deal team

Justin Lewis

Managing Director
Melbourne, Australia
Oaklins Henslow

Sebastian Bell

Director
Sydney, Australia
Oaklins Henslow

Related deals

VINCI Energies has acquired RH Marine and Bakker Sliedrecht
Construction & Engineering Services

VINCI Energies has acquired RH Marine and Bakker Sliedrecht

RH Marine and Bakker Sliedrecht have been acquired by VINCI Energies. With this transaction, VINCI Energies will gain market position in the Dutch maritime sector and strengthen its industrial portfolio.

Learn more
Vivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.
Healthcare

Vivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.

NEXXUS-IBERIA SGEIC, S.A. a private equity firm in Spain, has completed its acquisition of a majority stake in Vivo Diagnóstico. With this financial backing from NEXXUS-IBERIA, Vivo will focus on inorganic growth as well as investing in service quality, innovation and efficiency.

Learn more
Creo Medical Group plc has completed a US$15.7 million equity fundraise
Healthcare

Creo Medical Group plc has completed a US$15.7 million equity fundraise

Creo Medical Group plc, the provider of pioneering endoscopic healthcare solutions to clinicians and healthcare providers across the world, has completed a US$15.7 million (£12.1 million) equity fundraise.

Learn more